In the tumor microenvironment, MCs can be activated in different ways, including c-kit receptor stimulation by its ligand, stem cell factors, the IgE-dependent mechanism mediated by T lymphocyte–MC interaction, and TLR activation by other microenvironmental stimuli [58,59]. Here, IGHE is linked to neoplasm.